• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有关维生素 D 与 COVID-19 风险及其严重程度的证据。

Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity.

机构信息

Owner, Natural Health Partners, LLC, 125 SW 3rd Place, Cape Coral, FL 33991, USA.

Sunlight, Nutrition, and Health Research Center, P.O. Box 641603, San Francisco, CA 94164-1603, USA.

出版信息

Nutrients. 2020 Oct 31;12(11):3361. doi: 10.3390/nu12113361.

DOI:10.3390/nu12113361
PMID:33142828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7692080/
Abstract

Vitamin D deficiency co-exists in patients with COVID-19. At this time, dark skin color, increased age, the presence of pre-existing illnesses and vitamin D deficiency are features of severe COVID disease. Of these, only vitamin D deficiency is modifiable. Through its interactions with a multitude of cells, vitamin D may have several ways to reduce the risk of acute respiratory tract infections and COVID-19: reducing the survival and replication of viruses, reducing risk of inflammatory cytokine production, increasing angiotensin-converting enzyme 2 concentrations, and maintaining endothelial integrity. Fourteen observational studies offer evidence that serum 25-hydroxyvitamin D concentrations are inversely correlated with the incidence or severity of COVID-19. The evidence to date generally satisfies Hill's criteria for causality in a biological system, namely, strength of association, consistency, temporality, biological gradient, plausibility (e.g., mechanisms), and coherence, although experimental verification is lacking. Thus, the evidence seems strong enough that people and physicians can use or recommend vitamin D supplements to prevent or treat COVID-19 in light of their safety and wide therapeutic window. In view of public health policy, however, results of large-scale vitamin D randomized controlled trials are required and are currently in progress.

摘要

维生素 D 缺乏症与 COVID-19 患者共存。此时,肤色较深、年龄较大、存在既往疾病和维生素 D 缺乏是 COVID 疾病严重程度的特征。在这些特征中,只有维生素 D 缺乏是可以改变的。通过与多种细胞相互作用,维生素 D 可能有多种方式降低急性呼吸道感染和 COVID-19 的风险:降低病毒的存活和复制、降低炎症细胞因子产生的风险、增加血管紧张素转换酶 2 浓度、并维持内皮完整性。14 项观察性研究提供的证据表明,血清 25-羟维生素 D 浓度与 COVID-19 的发病率或严重程度呈负相关。迄今为止的证据在生物学系统中通常满足希尔因果关系的标准,即关联强度、一致性、时间性、生物学梯度、合理性(例如,机制)和一致性,尽管缺乏实验验证。因此,鉴于其安全性和广泛的治疗窗,证据似乎足够有力,人们和医生可以使用或推荐维生素 D 补充剂来预防或治疗 COVID-19。然而,鉴于公共卫生政策,需要并正在进行大规模维生素 D 随机对照试验的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301d/7692080/132ed67c1b5d/nutrients-12-03361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301d/7692080/546d2e9b0cf2/nutrients-12-03361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301d/7692080/132ed67c1b5d/nutrients-12-03361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301d/7692080/546d2e9b0cf2/nutrients-12-03361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301d/7692080/132ed67c1b5d/nutrients-12-03361-g002.jpg

相似文献

1
Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity.有关维生素 D 与 COVID-19 风险及其严重程度的证据。
Nutrients. 2020 Oct 31;12(11):3361. doi: 10.3390/nu12113361.
2
Point of view: Should COVID-19 patients be supplemented with vitamin D?观点:新冠病毒肺炎患者是否应该补充维生素 D?
Maturitas. 2020 Oct;140:24-26. doi: 10.1016/j.maturitas.2020.06.003. Epub 2020 Jun 8.
3
Vitamin D Deficiency and Outcome of COVID-19 Patients.维生素 D 缺乏与 COVID-19 患者结局的关系。
Nutrients. 2020 Sep 10;12(9):2757. doi: 10.3390/nu12092757.
4
Perspective: improving vitamin D status in the management of COVID-19.观点:改善维生素D状态在COVID-19管理中的作用
Eur J Clin Nutr. 2020 Jun;74(6):856-859. doi: 10.1038/s41430-020-0661-0. Epub 2020 May 12.
5
Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry.维生素 D 缺乏对 COVID-19 的影响——来自 CovILD 登记处的前瞻性分析。
Nutrients. 2020 Sep 11;12(9):2775. doi: 10.3390/nu12092775.
6
Role of vitamin D in preventing of COVID-19 infection, progression and severity.维生素 D 在预防 COVID-19 感染、进展和严重程度中的作用。
J Infect Public Health. 2020 Oct;13(10):1373-1380. doi: 10.1016/j.jiph.2020.06.021. Epub 2020 Jun 20.
7
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.证据表明,维生素 D 补充剂可能降低流感和 COVID-19 感染及死亡风险。
Nutrients. 2020 Apr 2;12(4):988. doi: 10.3390/nu12040988.
8
Vitamin D Insufficiency and Deficiency and Mortality from Respiratory Diseases in a Cohort of Older Adults: Potential for Limiting the Death Toll during and beyond the COVID-19 Pandemic?维生素 D 不足和缺乏与老年人呼吸系统疾病死亡率:在 COVID-19 大流行期间和之后限制死亡人数的潜力?
Nutrients. 2020 Aug 18;12(8):2488. doi: 10.3390/nu12082488.
9
Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study.维生素 D 补充与 COVID-19 住院虚弱老年患者生存改善相关:GERIA-COVID 准实验研究。
Nutrients. 2020 Nov 2;12(11):3377. doi: 10.3390/nu12113377.
10
Vitamin D and Sex Differences in COVID-19.维生素D与新冠病毒感染中的性别差异
Front Endocrinol (Lausanne). 2020 Sep 30;11:567824. doi: 10.3389/fendo.2020.567824. eCollection 2020.

引用本文的文献

1
Effects of vitamin D on COVID-19 risk and hospitalisation in the UK biobank.维生素D对英国生物银行中COVID-19风险及住院情况的影响。
PLoS One. 2025 Jul 18;20(7):e0328232. doi: 10.1371/journal.pone.0328232. eCollection 2025.
2
Impact of home confinement due to the COVID-19 outbreak on vitamin D levels and trends among children with pneumonia aged 1-35 months.COVID-19疫情导致的居家隔离对1至35个月大肺炎患儿维生素D水平及变化趋势的影响。
Pediatr Discov. 2023 Nov 5;2(1):e41. doi: 10.1002/pdi3.41. eCollection 2024 Mar.
3
Association between vitamin D deficiency and clinical outcome in patients with COVID-19 in the post-Omicron phase.

本文引用的文献

1
Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19.维生素 D 缺乏与内皮功能障碍相关:对 COVID-19 患者的影响。
Rev Cardiovasc Med. 2020 Sep 30;21(3):339-344. doi: 10.31083/j.rcm.2020.03.131.
2
Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.内皮功能障碍导致 COVID-19 相关的血管炎症和凝血异常。
Rev Cardiovasc Med. 2020 Sep 30;21(3):315-319. doi: 10.31083/j.rcm.2020.03.126.
3
Vitamin D and survival in COVID-19 patients: A quasi-experimental study.
奥密克戎变异株流行后期新冠病毒感染患者维生素D缺乏与临床结局的关联
Front Nutr. 2025 Jun 18;12:1583276. doi: 10.3389/fnut.2025.1583276. eCollection 2025.
4
The dynamic linkage between covid-19 and nutrition: a review from a probiotics perspective using machine learning and bibliometric analysis.2019冠状病毒病与营养之间的动态联系:基于机器学习和文献计量分析的益生菌视角综述
Front Nutr. 2025 May 9;12:1575130. doi: 10.3389/fnut.2025.1575130. eCollection 2025.
5
Vitamin D Status and Incidence of SARS-CoV-2 Reinfections in the Borriana COVID-19 Cohort: A Population-Based Prospective Cohort Study.博里亚纳新冠病毒感染队列中维生素D状态与新冠病毒再次感染的发生率:一项基于人群的前瞻性队列研究
Trop Med Infect Dis. 2025 Apr 6;10(4):98. doi: 10.3390/tropicalmed10040098.
6
Vitamin D deficiency and duration of COVID-19 symptoms in UK healthcare workers.英国医护人员的维生素D缺乏与新冠症状持续时间
Front Med (Lausanne). 2024 Nov 25;11:1494129. doi: 10.3389/fmed.2024.1494129. eCollection 2024.
7
Patterns of Dietary Supplement Use during the COVID-19 Pandemic in Poland: Focus on Vitamin D and Magnesium.新冠疫情期间波兰膳食补充剂使用模式:聚焦维生素 D 和镁。
Nutrients. 2024 Sep 24;16(19):3225. doi: 10.3390/nu16193225.
8
Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants.维生素 D:在 COVID-19 免疫中的关键角色,以及从大流行中吸取的对抗免疫逃避变异体的经验教训。
Inflammopharmacology. 2024 Dec;32(6):3631-3652. doi: 10.1007/s10787-024-01578-w. Epub 2024 Oct 16.
9
Oscillating spatiotemporal patterns of COVID-19 in the United States.美国新冠肺炎的振荡时空模式。
Sci Rep. 2024 Sep 16;14(1):21562. doi: 10.1038/s41598-024-72517-6.
10
Natural and socio-environmental factors in the transmission of COVID-19: a comprehensive analysis of epidemiology and mechanisms.新冠病毒传播的自然和社会环境因素:流行病学和机制的综合分析。
BMC Public Health. 2024 Aug 13;24(1):2196. doi: 10.1186/s12889-024-19749-3.
维生素 D 与 COVID-19 患者的生存:一项准实验研究。
J Steroid Biochem Mol Biol. 2020 Nov;204:105771. doi: 10.1016/j.jsbmb.2020.105771. Epub 2020 Oct 13.
4
Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study.血清维生素D水平是否会影响新型冠状病毒肺炎感染及其严重程度?一项病例对照研究。
J Am Coll Nutr. 2021 Nov-Dec;40(8):724-731. doi: 10.1080/07315724.2020.1826005. Epub 2020 Oct 13.
5
Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.SARS-CoV-2 引发的炎症反应和 ACE2 增强驱动严重 COVID-19 的多器官衰竭:分子机制及意义。
Inflammation. 2021 Feb;44(1):13-34. doi: 10.1007/s10753-020-01337-3. Epub 2020 Oct 8.
6
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.新型冠状病毒肺炎相关过度炎症综合征的临床标准:一项队列研究
Lancet Rheumatol. 2020 Dec;2(12):e754-e763. doi: 10.1016/S2665-9913(20)30343-X. Epub 2020 Sep 29.
7
How COVID-19 induces cytokine storm with high mortality.新冠病毒如何引发高死亡率的细胞因子风暴。
Inflamm Regen. 2020 Oct 1;40:37. doi: 10.1186/s41232-020-00146-3. eCollection 2020.
8
Effective Immune Functions of Micronutrients against SARS-CoV-2.微量营养素对 SARS-CoV-2 的有效免疫功能。
Nutrients. 2020 Sep 29;12(10):2992. doi: 10.3390/nu12102992.
9
Preliminary predictive criteria for COVID-19 cytokine storm.COVID-19 细胞因子风暴的初步预测标准。
Ann Rheum Dis. 2021 Jan;80(1):88-95. doi: 10.1136/annrheumdis-2020-218323. Epub 2020 Sep 25.
10
Point of view: Should COVID-19 patients be supplemented with vitamin D?观点:新冠病毒肺炎患者是否应该补充维生素 D?
Maturitas. 2020 Oct;140:24-26. doi: 10.1016/j.maturitas.2020.06.003. Epub 2020 Jun 8.